Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07368946 · ClinicalTrials.gov registry record · NA
Phosphate Assessment in Chronic Kidney Disease Patients Study
A NA study of Chronic Kidney Disease (Stage 3-4) and Chronic Kidney Disease Mineral and Bone Disorder, sponsored by University of Texas Southwestern Medical Center.
- Recruiting
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT07368946 is a NA study of Chronic Kidney Disease (Stage 3-4) and Chronic Kidney Disease Mineral and Bone Disorder that is actively recruiting participants, run by University of Texas Southwestern Medical Center. The registered enrollment target is 60 participants. The trial reports 1 study location across 1 state.
The verdict
NCT07368946, a NA study of Chronic Kidney Disease (Stage 3-4) and Chronic Kidney Disease Mineral and Bone Disorder, is actively recruiting participants, sponsored by University of Texas Southwestern Medical Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
The proposed pilot feeding study aims to explore novel pathways in phosphate metabolism and identify new biomarkers, as well as to develop a compound index for assessing phosphate overload with high validity and reliability. Investigators will address the following specific aims: 1). To explore novel pathways of phosphate metabolism and assess the influence of CKD status on these metabolic pathways. 2). To identify novel biomarkers for phosphate overload that reflect changes in dietary phosphorus intake. 3). To develop a compound phosphate overload index that measures dietary phosphorus intake with high validity and reliability. This study will provide novel insights into phosphate metabolism and the assessment of phosphate overload in CKD patients. This investigation aims to provide preliminary data to further studies for the development of reliable biomarkers in CKD patients, which could contribute significantly to early interventions and improve health outcomes.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Dietary Phosphorus Intake
Study Locations (1)
Texas
- University of Texas Southwestern Medical Center - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2025-05-09 |
| Est. Completion | 2026-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07368946
The ClinicalTrials.gov registry entry for NCT07368946 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Chronic Kidney Disease (Stage 3-4) appearing as the primary indexed condition, and to 1 intervention - of which Dietary Phosphorus Intake is the first listed.
NCT07368946 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT07368946 about?
NCT07368946 is a clinical study titled "Phosphate Assessment in Chronic Kidney Disease Patients Study". The proposed pilot feeding study aims to explore novel pathways in phosphate metabolism and identify new biomarkers, as well as to develop a compound index for assessing phosphate overload with high validity and reliability. Investigators will address the following specific aims: 1). To explore nov...
What is the current status of trial NCT07368946?
This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2025-05-09. Estimated completion is 2026-12-31.
What conditions does trial NCT07368946 study?
This clinical trial studies the following conditions: Chronic Kidney Disease (Stage 3-4), Chronic Kidney Disease Mineral and Bone Disorder.
What interventions are being tested in trial NCT07368946?
The interventions under investigation include: Dietary Phosphorus Intake (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT07368946?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07368946 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Kidney Disease (Stage 3-4)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Chronic Kidney Disease (Stage 3-4)
All registered trials for this condition
Chronic Kidney Disease Mineral and Bone Disorder
All registered trials for this condition
Texas
All trials with a study site in Texas
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.